These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12951277)

  • 41. Increased concentrations of serum pentosidine in rheumatoid arthritis.
    Rodríguez-García J; Requena JR; Rodríguez-Segade S
    Clin Chem; 1998 Feb; 44(2):250-5. PubMed ID: 9474020
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The advanced glycation end product pentosidine correlates to IL-6 and other relevant inflammatory markers in rheumatoid arthritis.
    Hein GE; Köhler M; Oelzner P; Stein G; Franke S
    Rheumatol Int; 2005 Dec; 26(2):137-41. PubMed ID: 15580352
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interleukin-8, nitric oxide and glutathione status in proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Cicik E; Tekin H; Akar S; Ekmekçi OB; Donma O; Koldaş L; Ozkan S
    Ophthalmic Res; 2003; 35(5):251-5. PubMed ID: 12920337
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advanced glycation end products: specific fluorescence changes of pentosidine-like compounds during short daily hemodialysis.
    Fagugli RM; Vanholder R; De Smet R; Selvi A; Antolini F; Lameire N; Floridi A; Buoncristiani U
    Int J Artif Organs; 2001 May; 24(5):256-62. PubMed ID: 11420874
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A quick, simple method for detecting circulating fluorescent advanced glycation end-products: Correlation with in vitro and in vivo non-enzymatic glycation.
    Villa M; Parravano M; Micheli A; Gaddini L; Matteucci A; Mallozzi C; Facchiano F; Malchiodi-Albedi F; Pricci F
    Metabolism; 2017 Jun; 71():64-69. PubMed ID: 28521879
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasma levels of pentosidine in diabetic patients: an advanced glycation end product.
    Sugiyama S; Miyata T; Ueda Y; Tanaka H; Maeda K; Kawashima S; Van Ypersele de Strihou C; Kurokawa K
    J Am Soc Nephrol; 1998 Sep; 9(9):1681-8. PubMed ID: 9727377
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diabetes-induced oxidative stress in the vitreous humor.
    Géhl Z; Bakondi E; Resch MD; Hegedűs C; Kovács K; Lakatos P; Szabó A; Nagy Z; Virág L
    Redox Biol; 2016 Oct; 9():100-103. PubMed ID: 27454767
    [TBL] [Abstract][Full Text] [Related]  

  • 49. FACTORS ASSOCIATED WITH PENTOSIDINE ACCUMULATION IN THE HUMAN VITREOUS.
    van Deemter M; Bank RA; Vehof J; Hooymans JM; Los LI
    Retina; 2017 Apr; 37(4):770-777. PubMed ID: 27465571
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study.
    Fosmark DS; Bragadóttir R; Stene-Johansen I; Berg JP; Berg TJ; Lund T; Sandvik L; Hanssen KF
    Acta Ophthalmol Scand; 2007 Sep; 85(6):618-22. PubMed ID: 17488318
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Marked increases in macrophage colony-stimulating factor and interleukin-18 in maintenance hemodialysis patients: comparative study of advanced glycation end products, carboxymethyllysine and pentosidine.
    Uchimura T; Motomiya Y; Okamura H; Hashiguchi T; Miura M; Uji Y; Iwamoto H; Maruyama I
    Nephron; 2002 Apr; 90(4):401-7. PubMed ID: 11961398
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Levels of selected oxidative stress markers in the vitreous and serum of diabetic retinopathy patients.
    Brzović-Šarić V; Landeka I; Šarić B; Barberić M; Andrijašević L; Cerovski B; Oršolić N; Đikić D
    Mol Vis; 2015; 21():649-64. PubMed ID: 26120270
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Roles of endothelin-1 and selected proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy: Analysis of vitreous samples.
    Adamiec-Mroczek J; Oficjalska-Młyńczak J; Misiuk-Hojło M
    Cytokine; 2010 Mar; 49(3):269-74. PubMed ID: 20015663
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Soluble IL-6 receptor in vitreous fluid of patients with proliferative diabetic retinopathy.
    Kawashima M; Shoji J; Nakajima M; Kamura Y; Sato Y
    Jpn J Ophthalmol; 2007; 51(2):100-4. PubMed ID: 17401618
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of dialysis modalities on serum AGE levels in end-stage renal disease patients.
    Stein G; Franke S; Mahiout A; Schneider S; Sperschneider H; Borst S; Vienken J
    Nephrol Dial Transplant; 2001 May; 16(5):999-1008. PubMed ID: 11328907
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between aqueous humor and vitreous fluid levels of Th17 cell-related cytokines in patients with proliferative diabetic retinopathy.
    Takeuchi M; Sato T; Sakurai Y; Taguchi M; Harimoto K; Karasawa Y; Ito M
    PLoS One; 2017; 12(5):e0178230. PubMed ID: 28558009
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Skin collagen pentosidine and fluorescence in diabetes were predictors of retinopathy progression and creatininemia increase already 6years after punch-biopsy.
    Sternberg M; M'bemba J; Urios P; Borsos AM; Selam JL; Peyroux J; Slama G
    Clin Biochem; 2016 Feb; 49(3):225-31. PubMed ID: 26506116
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased IL-6 levels are not related to NF-κB or HIF-1α transcription factors activity in the vitreous of proliferative diabetic retinopathy.
    Arjamaa O; Pöllönen M; Kinnunen K; Ryhänen T; Kaarniranta K
    J Diabetes Complications; 2011; 25(6):393-7. PubMed ID: 21813290
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Angiotensin II receptor blocker inhibits abnormal accumulation of advanced glycation end products and retinal damage in a rat model of type 2 diabetes.
    Sugiyama T; Okuno T; Fukuhara M; Oku H; Ikeda T; Obayashi H; Ohta M; Fukui M; Hasegawa G; Nakamura N
    Exp Eye Res; 2007 Sep; 85(3):406-12. PubMed ID: 17678894
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of 150-kDa oxygen-regulated protein with vascular endothelial growth factor in proliferative diabetic retinopathy.
    Abu El-Asrar AM; Ahmad A; Alam K; Bittoun E; Siddiquei MM; Mohammad G; Mousa A; De Hertogh G; Opdenakker G
    Acta Ophthalmol; 2018 Jun; 96(4):e460-e467. PubMed ID: 29098793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.